COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Autres communiqués
GenSight Biologics annonce le règlement-livraison de sa levée de fonds de 1,7 millions d’euros. La société biopharmaceutique se spécialise dans les thérapies géniques pour les maladies neurodégénératives, notamment de la rétine et du système nerveux central -
-
-
COMMUNIQUÉ DE PRESSE
Announcement regarding a vote without a shareholders’ meeting concerning non-compliance with a financial ratio as of the end of the fiscal year 2025 and the waiver of a review of this financial ratio
Mutares SE & Co. KGaA announces vote on financial ratio non-compliance and waiver. Bondholders to grant consent via written resolution with fee. Details in attached links -
COMMUNIQUÉ DE PRESSE
Darwin AG launches commercialization of Multi-Cancer Check — a blood test for early detection of 13 types of cancer
Darwin AG launches Multi-Cancer Check, a blood test for early detection of 13 types of cancer, setting new standards in preventive oncology with high sensitivity and specificity -
-
-
